Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug By: Benzinga via Benzinga February 25, 2015 at 12:57 PM EST Bristol-Myers Squibb Co (NYSE: BMY) launched a Phase III trial of an experimental HIV treatment for patients who have become ... Read More >> Related Stocks: Bristol-Myers Squibb